Septerna Inc's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026New directors join the board, affecting company leadership and decision-making for investors.
Quarterly earnings show how the company is performing and whether it's growing or shrinking.
Independent auditors check the company's finances; shareholders voting confirms trust in oversight.
Companies share updates to keep investors informed about strategy and progress.
Annual reports show total yearly performance, helping investors understand long-term company health.
Year-end earnings reveal whether the company met goals and how it finished the year.
Successful drug trials move products toward market, potentially creating future revenue and value.
Stocky reads Septerna Inc's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Septerna Inc's most recent tracked filing was a 8-K on 30 Jun 2026: Shareholders elect Sharp and Simson to board for three years.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.